Evidence map›Paper›PMID 31105820›Full record

ArticleAmerican journal of translational research2019

Euscaphic acid inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.

Weibo Dai, Pengpeng Dong, Jing Liu, Yuqiao Gao, Ying Hu, Hui Lin, Ye Song, Quanxi Mei

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Relationship of PI3K-Akt/mTOR/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Weibo DaiPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Pengpeng DongDepartment of New Drug Analysis, New Drug Institute, Sunshine Lake Pharma Co., Ltd Dongguan 523871, Republic of China.
Jing LiuDepartment of Biomedicine, Zhongshan Torch Polytechnic Zhongshan 528436, Republic of China.
Yuqiao GaoPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Ying HuPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Hui LinPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Ye SongPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Quanxi MeiPharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine Zhongshan 528401, Republic of China.
Zhongshan Hospital · CNInternational Drug Development · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AKTEuscaphic acidmTORnasopharyngeal carcinomaPI3K

Identifiers

PMID31105820
PMCPMC6511751
OpenAlexW3021497131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.